Septodont OraVerse® anesthesia reversal agent by Septodont is a breakthrough product that reverses unwanted lingering numbness after routine dental procedures where a local anesthetic containing a vasoconstrictor was used. It is indicated for reversal of soft-tissue anesthesia.
In clinical trials, the median time to recovery of normal sensation in the upper lip was 50 minutes for OraVerse patients vs. 133 minutes for the control group; in addition, the lower lip was 70 minutes recovery for OraVerse patients vs. 155 minutes for the control. OraVerse helps patients quickly be able to smile, speak, and drink liquids after procedures, as well as minimize drooling.
Benefits:
- Phentolamine mesylate injection.
- Patients should be at least 6 years old and weigh 33 pounds (not recommended for children less than 3 years old).
- Allows diabetics to stay on their eating schedule.
